Phase II study of 5-fluorouracil and leucovorin in recurrent primary brain tumor

被引：0
|
作者：
Cascino, TL
Veeder, MH
Buckner, JC
OFallon, JR
Wiesenfeld, M
Levitt, R
Goldberg, RM
Kuross, SA
Morton, RF
Scheithauer, BW
机构：
[1] ILLINOIS ONCOL RES ASSOC,COMMUNITY CLIN ONCOL PROGRAM,PEORIA,IL 61602
[2] CEDAR RAPIDS ONCOL PROJECT,CCOP,CEDAR RAPIDS,IA 52403
[3] MERITCARE HOSP,CCOP,FARGO,ND 58123
[4] GEISINGER CLIN ONCOL PROGRAM,DANVILLE,PA 17822
[5] DULUTH COMMUNITY CLIN ONCOL PROGRAM,DULUTH,MN 55805
[6] IOWA ONCOL RES ASSOC,CCOP,DES MOINES,IA 50314
来源：
JOURNAL OF NEURO-ONCOLOGY | 1996年 / 30卷 / 03期
关键词：
recurrent glioma; 5-fluorouracil; leucovorin; radiation therapy; astrocytoma; oligodendroglioma;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Thirty patients with recurrent primary brain tumors were treated with a combination of 5-fluorouracil and leucovorin. There were three responses seen. Toxicity consisted of stomatitis, diarrhea, and hematological suppression. 5-fluorouracil and leucovorin would appear to be minimally effective in recurrent brain tumors.
引用
收藏
页码：243 / 246
页数：4
相关论文
共 50 条
  • [11] A phase I study of sequential irinotecan and 5-fluorouracil/leucovorin
    Goldberg, RM
    Kaufmann, SH
    Atherton, P
    Sloan, JA
    Adjei, AA
    Pitot, HC
    Alberts, SR
    Rubin, J
    Miller, LL
    Erlichman, C
    ANNALS OF ONCOLOGY, 2002, 13 (10) : 1674 - 1680
  • [12] A phase I study of docetaxel, cisplatin, 5-fluorouracil and leucovorin
    Mulcahy, MF
    Loehrer, PJ
    Meropol, NJ
    Rademaker, AW
    Benson, AB
    ONCOLOGY, 2005, 68 (4-6) : 479 - 484
  • [13] Phase II study of irinotecan and 5-fluorouracil/leucovorin in patients with primary refractory or relapsed advanced oesophageal and gastric carcinoma
    Assersohn, L
    Brown, G
    Cunningham, D
    Ward, C
    Oates, J
    Waters, JS
    Hill, ME
    Norman, AR
    ANNALS OF ONCOLOGY, 2004, 15 (01) : 64 - 69
  • [14] Phase II trial of 5-fluorouracil and high-dose leucovorin in recurrent adenocarcinoma of the cervix: A gynecologic oncology group study
    Look, KY
    Blessing, JA
    Valea, FA
    McGehee, R
    Manetta, A
    Webster, KD
    Andersen, WA
    GYNECOLOGIC ONCOLOGY, 1997, 67 (03) : 255 - 258
  • [15] A PHASE-II STUDY OF OUTPATIENT CHEMOTHERAPY WITH CISPLATIN, 5-FLUOROURACIL, AND LEUCOVORIN IN NASOPHARYNGEAL CARCINOMA
    CHI, KH
    CHAN, WK
    COOPER, DL
    YEN, SH
    LIN, CZ
    CHEN, KY
    CANCER, 1994, 73 (02) : 247 - 252
  • [16] Phase II study of oral eniluracil, 5-fluorouracil, and leucovorin in patients with advanced colorectal carcinoma
    Meropol, NJ
    Niedzwiecki, D
    Hollis, D
    Schilsky, RL
    Mayer, RJ
    CANCER, 2001, 91 (07) : 1256 - 1263
  • [17] ETOPOSIDE, LEUCOVORIN AND 5-FLUOROURACIL IN ADVANCED GASTRIC-CANCER - A PHASE-II STUDY
    VANCUTSEM, E
    FILEZ, L
    DEWYSPELAERE, J
    PENNINCKX, F
    JANSSENS, J
    ANTICANCER RESEARCH, 1995, 15 (03) : 1079 - 1080
  • [18] A PHASE I-II STUDY OF EPIRUBICIN, 5-FLUOROURACIL, AND LEUCOVORIN IN ADVANCED ADENOCARCINOMA OF THE STOMACH
    KORNEK, G
    SCHULZ, F
    DEPISCH, D
    ROSEN, H
    KWASNY, W
    SEBESTA, C
    SCHEITHAUER, W
    CANCER, 1993, 71 (07) : 2177 - 2180
  • [19] Phase II study of cisplatin, 5-fluorouracil, and leucovorin in inoperable squamous cell carcinoma of the esophagus
    Feliu, J
    Baron, MG
    Giron, CG
    Espinosa, E
    Vicent, JM
    Navarro, JG
    Berrocal, A
    Ordonez, A
    Vilches, Y
    deCastro, J
    Diaz, J
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1996, 19 (06): : 577 - 580
  • [20] Docetaxel, 5-fluorouracil, and leucovorin as treatment for advanced gastric cancer: Results of a phase II study
    Constenla M.
    Garcia-Arroyo R.
    Lorenzo I.
    Carrete N.
    Campos B.
    Palacios P.
    Gastric Cancer, 2002, 5 (3) : 142 - 147
12345